Delivery Order SPE2DX22D0010-SPE2D825FJB73
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 4, 2025, for the supply of Concerta ER 36 mg tablets (100 count units) with a ceiling value of $4,310.92. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 5, 2025. The award fulfills the federal government's pharmaceutical...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,205.60 for Concerta ER Tablets 54mg, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's broader relationship with the Defense Logistics Agency. The contract was executed on July 29, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $18,949.34 on August 12, 2025, for the supply of Concerta ER Tabs 36mg. The contract, which is set to be completed by August 13, 2025, is funded by the Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,289.80 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 6, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This firm fixed-price delivery order, valued at $15,886.60, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,591.14 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Concerta ER Tablets 36mg. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract requires completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $19,079.33 by the Defense Logistics Agency (DLA) for the supply of Concerta ER 27 mg tablets (100-count units). This competitively awarded, firm fixed-price contract is non-set-aside and was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $6,600.47 for Concerta ER 18 mg tablets (100-count packages). This competitive, firm fixed-price contract was awarded on June 18, 2025, with an ultimate completion date of June 20, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Concerta ER Tablets 36mg, with a ceiling value of $22,714.79. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 12, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $5,679.26. The award is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside contract. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJB73Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $24,486.26 for Concerta ER Tablets 36mg on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price, non-set-aside contract is funded by the Defense Logistics Agency's Medical Supply Chain division and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a prime vendor vehicle valued at $999,999,999.00 and extending through December 2026. This contract supports the company's role as a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems, including military and veteran programs. AmerisourceBergen's comprehensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products, including brand-name and generic medications, across multiple therapeutic domains. The award of this delivery order under the larger prime vendor IDC highlights the vendor's continued qualification to meet Department of Defense medical procurement requirements through open competition and its ability to fulfill pharmaceutical needs for Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.5k | 9/3/25 |